Comparison of IVIG resistance predictive models in Kawasaki disease

被引:0
|
作者
Ummusen Kaya Akca
Elif Arslanoglu Aydin
Hayrettin Hakan Aykan
Oguzhan Serin
Erdal Sag
Selcan Demir
Erdal Atalay
Muserref Kasap
Ezgi Deniz Batu
Tevfik Karagoz
Yelda Bilginer
Seza Ozen
机构
[1] Hacettepe University,Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine
[2] Hacettepe University,Department of Pediatrics, Faculty of Medicine
[3] Hacettepe University,Division of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine
来源
Pediatric Research | 2022年 / 91卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:621 / 626
页数:5
相关论文
共 50 条
  • [41] Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease
    Duan, Yan
    Li, Hui
    Luo, Dinghua
    Jiang, Jun
    Liu, Bin
    Li, Gang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [42] The Performance of the Kobayashi and Egami Scores in Detecting IVIG Resistance in Kawasaki Disease in a Single Centre Canadian Cohort Treated with IVIG and Low Dose Aspirin
    Basodan, Dania
    Scuccimarri, Rosie
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [43] Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
    Han, Chun-Ling
    Zhao, Suo-Lin
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7264 - 7270
  • [44] IVIG Reduced Vascular Oxidative Stress in Patients With Kawasaki Disease
    Takatsuki, Shinichi
    Ito, Yuka
    Takeuchi, Daiji
    Hoshida, Hiroshi
    Nakayama, Tomotaka
    Matsuura, Hiroyuki
    Saji, Tsutomu
    CIRCULATION JOURNAL, 2009, 73 (07) : 1315 - 1318
  • [45] The addition of glucocorticoids to initial IVIG therapy in children with Kawasaki Disease
    Shiari, Reza
    Beirami, Farzaneh
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 432 - 432
  • [46] Triptolide as an Alternative to IVIG Therapy for Kawasaki Disease in a Mouse Model
    Yan, Zong-Ting
    Zou, Jian-Wen
    BALKAN MEDICAL JOURNAL, 2013, 30 (02) : 225 - 228
  • [47] Lessons from Kawasaki disease: All brands of IVIG are not equal
    Stiehm, ER
    JOURNAL OF PEDIATRICS, 2006, 148 (01): : 6 - 8
  • [49] Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
    Portman, Michael A.
    Dahdah, Nagib S.
    Slee, April
    Olson, Aaron K.
    Choueiter, Nadine F.
    Soriano, Brian D.
    Buddhe, Sujatha
    Altman, Carolyn A.
    Del Toro, Kamill
    Kourtidou, Soultana
    Wisotzkey, Bethany
    Bruce, Margaret
    Cox, Jennifer
    Williams, Richard
    Reeder, Jamie
    Kirkpatrick, Edward
    Malloy, Marsha
    Krolikowslki, Mary
    Briere, Julie
    Breault, Fabiola
    Rajan, Sujatha
    Mensch, Deborah
    Stellato, Nancy
    Rubin, Lorry
    Sood, Sunil
    Leibowitz, Jill
    Shah, Rita
    Soma, Vijaya
    Cooper, Rubin
    DeMers, Christine
    Sexson-Tejtel, Sara K.
    Griffin, Debra
    Shittu, Teniola
    Munjal, Iona
    Balem, Kelly Ann
    Imundo, Lisa
    Isgro, Josephine
    Ferris, Anne
    Slee, April
    PEDIATRICS, 2019, 143 (06)
  • [50] The Performance of the Kobayashi and Egami Scores in Detecting IVIG Resistance in Kawasaki Disease in a Large Single Centre Canadian Cohort Treated with IVIG and Low Dose Aspirin
    Basodan, Dania
    Dallaire, Frederic
    Saulnier, Harrison
    Scuccimarri, Rosie
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 946 - 946